Trastuzumab Completed Phase 4 Trials for Cancer, Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02445586Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer
NCT01301729A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment
NCT00127933XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer